[Sclerosing pneumocytoma: A rare and benign tumor]. 2020

Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
Service de Pneumologie et Soins Intensifs Respiratoires, Centre de Référence Constitutif des maladies Pulmonaires rares de l'Adulte de Dijon, réseau OrphaLung, Filère RespiFil, Centre Hospitalier Universitaire de Bourgogne, Dijon, France.

BACKGROUND Sclerosing pneumocytoma is a benign and rare lung tumor affecting epithelial cells. In most cases, patients are asymptomatic and the diagnosis is made on an X ray or a CT scan performed for other enquiry. Sex ratio favors women. Epidemiological studies report that middle-aged Asian women are more frequently affected. Radiological investigations find a solitary nodule or a mass with peripheric localization. When performed, histological analysis shows a tumor composed of at least two of the four following architectures: papillary, sclerosing, hemangiomatous and solid, with two types of cells that can be round or cubic cells. METHODS We report two cases of multiple sclerosing pneumocytoma in two caucasien men. The first patient was asymptomatic, the second complain from moderate dyspnea. A wedge resection was performed in both, allowing diagnosis. Anatomopathology revealed respectively a predominant sclerosing and solid architecture and a sclerosing and papillary architecture. There was no progression of the other concomitant nodules after three years follow-up. CONCLUSIONS Pneumocytoma is a benign, slow-growing tumor with good prognosis.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013902 Radiography, Thoracic X-ray visualization of the chest and organs of the thoracic cavity. It is not restricted to visualization of the lungs. Thoracic Radiography,Radiographies, Thoracic,Thoracic Radiographies
D047868 Pulmonary Sclerosing Hemangioma A benign neoplasm of pneumocytes, cells of the PULMONARY ALVEOLI. Originally considered to be vascular in origin, it is now classified as an epithelial tumor with several elements, including solid cellular areas, papillary structure, sclerotic regions, and dilated blood-filled spaces resembling HEMANGIOMA. Sclerosing Hemangioma of the Lung,Hemangioma, Sclerosing, Pulmonary,Lung Sclerosing Hemangioma,Sclerosing Hemangioma, Lung,Lung Sclerosing Hemangiomas,Pulmonary Sclerosing Hemangiomas,Sclerosing Hemangioma, Pulmonary,Sclerosing Hemangiomas, Lung,Sclerosing Hemangiomas, Pulmonary
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
January 2023, Indian journal of pathology & microbiology,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
January 1983, Le Poumon et le coeur,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
January 2019, Respiratory medicine case reports,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
June 1982, Thorax,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
March 2013, Respiratory medicine,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
January 1999, Polish journal of pathology : official journal of the Polish Society of Pathologists,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
June 2021, Thoracic cancer,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
January 2017, International journal of clinical and experimental pathology,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
September 2005, Der Pathologe,
Y Hassani, and S Ramla, and A Zouak, and N Ahouansou, and G Beltramo, and P-B Pages, and M Georges, and P Bonniaud
November 1988, Ceskoslovenska patologie,
Copied contents to your clipboard!